| RE50030 |
Methods to treat lymphoplasmacytic lymphoma |
Steven P. Treon, Sara Jean Buhrlage, Nathanael S. Gray, Guang Yang |
2024-07-02 |
| 10925868 |
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use |
Nathanael S. Gray, James E. Bradner, Hai-Tsang Huang, Dennis Buckley, Georg Winter +1 more |
2021-02-23 |
| 10906878 |
Kinase inhibitors for the treatment of disease |
Nathanael S. Gray, Hwan Geun Choi |
2021-02-02 |
| 10633348 |
Methods to treat lymphoplasmacytic lymphoma |
Steven P. Treon, Sara Jean Buhrlage, Nathanael S. Gray, Guang Yang |
2020-04-28 |
| 10597387 |
Methods to treat lymphoplasmacytic lymphoma |
Steven P. Treon, Sara Jean Buhrlage, Nathanael S. Gray, Guang Yang |
2020-03-24 |
| 10525060 |
HCK as a therapeutic target in MYD88 mutated diseases |
Steven P. Treon, Guang Yang, Nathanael S. Gray, Sara Jean Buhrlage |
2020-01-07 |
| 10316002 |
Kinase inhibitors for the treatment of disease |
Nathanael S. Gray, Hwan Geun Choi |
2019-06-11 |
| 10124008 |
Use of inhibitors of acid sphingomyelinase to treat acquired and inherited retinal degenerations |
Aparna Lakkaraju, Kimberly A. Toops |
2018-11-13 |
| 10017477 |
Janus kinase inhibitors and uses thereof |
Nathanael S. Gray |
2018-07-10 |
| 9908872 |
Methods to treat lymphoplasmacytic lymphoma |
Steven P. Treon, Sara Jean Buhrlage, Nathanael S. Gray, Guang Yang |
2018-03-06 |
| 9862688 |
Hydrophobically tagged janus kinase inhibitors and uses thereof |
Nathanael S. Gray |
2018-01-09 |
| 9856223 |
Methods to treat lymphoplasmacytic lymphoma |
Steven P. Treon, Sara Jean Buhrlage, Nathanael S. Gray, Guang Yang |
2018-01-02 |
| 9783504 |
Kinase inhibitors for the treatment of disease |
Nathanael S. Gray, Hwan Geun Choi |
2017-10-10 |
